Case 2: 46-year-old Woman With SM

EP: 1.Systemic Mastocytosis: Epidemiology and Diagnostic Criteria

EP: 2.Considerations in Mast Cell Disorders

EP: 3.Considerations in SM: Hereditary Alpha Tryptasemia

EP: 4.Case 1: 75-Year-Old Man With SM

EP: 5.Case 1: Treatment and Management Considerations

EP: 6.Case 1: Treatment Algorithm and Supportive Care Recommendations

Now Viewing

EP: 7.Case 2: 46-year-old Woman With SM

EP: 8.Case 2: Treatment and Management Considerations for SM

EP: 9.Case 2: SM Treatment Algorithm and Supportive Care Recommendations

EP: 10.PATHFINDER Trial Efficacy Data

EP: 11.Avapritinib: Approval and Clinical Practice Implications

EP: 12.Case 3: Indolent Systemic Mastocytosis

EP: 13.Case 4: A 68-Year-Old Female With Mast Cell Leukemia

EP: 14.Case 4: Treatment and Management Considerations in MCL

EP: 15.Advanced Systemic Mastocytosis: Expert Insight into Epidemiology, Diagnosis, and Treatment

EP: 16.Case 5: A 24-Year-Old Female With Well-Differentiated SM

EP: 17.Well-Differentiated Systemic Mastocytosis vs Chronic Mast Cell Leukemia

EP: 18.Case 6: 47-Year-Old Male With Leukocytosis, Anemia, and Splenomegaly

EP: 19.Chronic Myelomonocytic Cell Leukemia: Clinical Considerations

EP: 20.Unmet Needs in SM Treatment

Dan DeAngelo, MD, PhD: Let me bring on a second case. She’s a wonderful woman. Ashley was referred about 15 or 16 years ago to me because she was in hospice care, believe it or not. She was being managed locally. She was having chronic diarrhea, weight loss, and abdominal distention to the point that she weighed about 40 kg. She had an indwelling catheter for TPN [total parenteral nutrition]. That’s how I inherited her. Her numbers had a tryptase of 770 ng/mL with a histamine level through the roof. CT [computed tomography] scan showed just dense ascites and hepatosplenomegaly. She had esophageal varices and gastric erythema, so there was evidence of portal hypertension, and a colonoscopy that showed pan-colonic edema with cecum, ascending transverse and descending colon throughout. Transjugular liver biopsy showed an elevated gradient. Marrow had more that 30% mast cells.

One of the things I wanted to bring to your attention are some of the GI [gastrointestinal] symptoms in mast cell disease. It’s highlighted in this particular case. I’ve highlighted her issues in red as she presented. But patients can have GI involvement of their mast cell disease and often get misdiagnosed as irritable bowel disease or other types of colitis. They present with abdominal pain due to gut motility or diarrhea, nausea due to some hyperacid secretion or delayed stomach emptying, vomiting from the same process sometimes from organomegaly but sometimes delayed emptying. Peptic ulcer disease, which is not uncommon in these patients because of the elevated histamine. This particular individual’s history was through the roof. GI bleeding due to histamine-induced acid secretion. Weight loss and malnutrition due to mast effect, the mast cell infiltration impeding normal gut absorption. Consequently, she really manifested many of these problems. These are just highlights of her histopathology.

This is a low power view of the H&E [hematoxylin and eosin] of her bone marrow. Here’s a bone marrow biopsy showing a KIT stain, the CD117. This is a tryptase, and this may highlight what Dr [Sa] Wang had mentioned. The CD117 is highlighting the vast majority of the mast cells vs tryptase, which is highlighting only a few. Because some of these are so dysregulated, they’re no longer staining tryptase. This is aberrant CD25, highlighting the bulk. Then this is a small intestinal biopsy from this patient, and I would argue that with H&E at this low power, you’re not able to see anything. I’m not a pathologist, but even at high power, I couldn’t tell you. There seems to be too many cells in the micrograph. But when you do the CD117 stain, you see that those cells are mast cells. There are a lot of mast cells in this GI biopsy, and they do stain for tryptase.

Transcript edited for clarity.